<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01991470</url>
  </required_header>
  <id_info>
    <org_study_id>CEP249</org_study_id>
    <nct_id>NCT01991470</nct_id>
  </id_info>
  <brief_title>CEP249 Pediatric Accuracy Study</brief_title>
  <official_title>A Performance Evaluation of the Enlite™ and Enlite 3 Glucose Sensor to Support Use in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Diabetes</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Diabetes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the Enlite Sensor™ and Enlite 3 Sensor performance
      in pediatric patients with insulin requiring diabetes at the beginning, middle and end of
      sensor wear.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a prospective, single arm, multi-center, in-clinic study with one treatment
      group assignment. There will be two consecutive phases of the study:

      A total of up to 260 subjects will be enrolled at up to 15 investigational centers

      Subjects will come for clinic visit for YSI testing

      Study has a run-in period and a study period with a total of 10 visits
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensor accuracy with minimum calibrations</measure>
    <time_frame>6 days/7days</time_frame>
    <description>Glucose sensor values will be compared to Yellow Spring Instruments (YSI) plasma glucose values during Frequent Sample Testing. For subjects 2-6 yeard of age, SMBG may be used as a reference value.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">191</enrollment>
  <condition>Insulin Requiring Diabetes</condition>
  <arm_group>
    <arm_group_label>2-18 year olds with Insulin requiring diabetes.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each subject will wear enlite and / or enlite 3 sensors and will undergo 1 or 2 frequent sample tests, in-clinic</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sensor</intervention_name>
    <description>Subject wears both enlite and enlite 3 sensors</description>
    <arm_group_label>2-18 year olds with Insulin requiring diabetes.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is 2-18 years of age at time of screening

          2. Subject has been diagnosed with insulin requiring diabetes mellitus for at least one
             year.

          3. Subject is willing to perform greater than or equal to 4 finger stick blood glucose
             measurements daily

          4. Subject is willing to perform required sensor calibrations

          5. Subject is willing to wear the system (Guardian Mobile application, pumps, sensors,
             meter) continuously throughout the study

          6. Adequate venous access as assessed by investigator or appropriate staff

        Exclusion Criteria:

          1. Subject is unable to tolerate tape adhesive in the area of sensor placement

          2. Subject has any unresolved adverse skin condition in the area of sensor or device
             placement (e.g., psoriasis, rash, Staphylococcus infection)

          3. Subject is actively participating in an investigational study (drug or device) wherein
             they have received treatment from an investigational study (drug or device) in the
             last 2 weeks

          4. Females of child-bearing potential who have a positive pregnancy test at screening or
             plans to become pregnant during the course of the study

          5. Subjects with hematocrit lower than the normal age specific reference range per
             central or local lab testing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald Brazg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rainier Clinical Research Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Timothy Bailey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AMCR Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeanie Tryggestad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>OUHSC Department of Pediatrics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Linda DiMeglio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University, Riley Hospital for Children</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Larry Fox, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nemours Children's Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jennifer Sherr, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University, Yale Diabetes Research Program</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Slover, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barbara Davis Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eva Tsalikian, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa Children Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bruce Bode, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Atlanta Diabetes Associates</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kevin Kaiserman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SoCal Diabetes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Christiansen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Diablo Clinical Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AMCR Institute</name>
      <address>
        <city>Escondido</city>
        <state>California</state>
        <zip>92025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SoCal Diabetes</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diablo Clinical Research</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <zip>94598</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barbara Davis Center</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale University, Yale Diabetes Research Program</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06511</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Atlanta Diabetes Associates</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30318</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University, Riley Hospital for Children</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa Children Hospital</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OUHSC Department of Pediatrics</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rainier Clinical Research Center</name>
      <address>
        <city>Renton</city>
        <state>Washington</state>
        <zip>98057</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2013</study_first_submitted>
  <study_first_submitted_qc>November 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2013</study_first_posted>
  <last_update_submitted>January 11, 2017</last_update_submitted>
  <last_update_submitted_qc>January 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Insulin requiring diabetes</keyword>
  <keyword>Children</keyword>
  <keyword>Sensor</keyword>
  <keyword>Accuracy</keyword>
  <pending_results>
    <submitted>December 19, 2017</submitted>
    <returned>January 19, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

